Aardvark Labs Aardvark Labs Capital Research Reports Tickers Models Calendar About & Disclosures Log in 中文日本語한국어

← All companies

Novo Nordisk A/S

Novo Nordisk A/S (NVO)

Hold Current rating · 2 reports

2026-08-05

Hold Recap: Q2 2026

Guidance Up Six Points, Stock Down Six Percent: The Pill Works, US Wegovy Injectable Falls 22%

2026-05-07

Hold Recap: Q1 2026

Wegovy Pill Sets a Launch Record, and Novo Still Under-Grew an 85% US Obesity Market

The depth and quality Wall Street pays for — free.

Missed the earnings call? Don't miss our breakdown.

About & Disclosures · Privacy · Terms

© 2026 Aardvark Labs Capital Research. All rights reserved.